If you are at 1.0 mg, move to 1.25 mg or 1.5 mg
With Wegovy, Mounjaro, and Zepbound, flow checks are not required
Zepbound is a combined glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults who are obese or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, high cholesterol, or cardiovascular disease and is to be used in addition to a reduced calorie diet and increased physical activity
Renal Protection The kidneys are susceptible to damage from prolonged inflammation and hyperglycemia
3-Chlorophenyl compounds 5-HT3 receptor negative allosteric modulators Anorectics Antidepressants Anti-obesity drugs Aphrodisiacs Attention deficit hyperactivity disorder management Cathinones CYP2D6 inhibitors Designer drugs Dermatoxins Drugs developed by GSK plc Ergogenic aids Female sexual dysfunction drugs Nicotinic antagonists Norepinephrinedopamine reuptake inhibitors Pro-motivational agents Prodrugs Sigma receptor modulators Smoking cessation Stimulants Tert-butyl compounds Wakefulness-promoting agents World Health Organization essential medicines
Give us a call or book an appointment online, and lets figure out together what your body actually needs.